Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
59.65
0.00 (0.00%)
At close: Apr 27, 2026
437.39%
Market Cap 238.60B
Revenue (ttm) 77.69B
Net Income (ttm) 6.46B
Shares Out 4.00B
EPS (ttm) 1.62
PE Ratio 36.92
Forward PE n/a
Dividend 0.32 (0.54%)
Ex-Dividend Date Apr 24, 2026
Volume 154,500
Average Volume 442,621
Open n/a
Previous Close 59.65
Day's Range n/a
52-Week Range 11.10 - 104.00
Beta 1.43
RSI 30.55
Earnings Date Apr 28, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 195
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements

News

There is no news available yet.